Skip to content
The Policy VaultThe Policy Vault

orlistat 120 mg (Xenical, authorized generic)Medical Mutual

Weight Loss, Pediatric

Initial criteria

  • Patient is ≥ 12 years of age and < 18 years of age; AND
  • Patient currently has a BMI ≥ 95th percentile for age and sex; AND
  • Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months and has failed to limit weight gain or modify comorbidities; AND
  • Patient is currently engaged in behavioral modification and on a reduced calorie diet

Reauthorization criteria

  • Patient is ≥ 12 years of age and < 18 years of age; AND
  • Patient had an initial BMI ≥ 95th percentile for age and sex; AND
  • Patient is currently engaged in behavioral modification and on a reduced calorie diet; AND
  • Patient’s current BMI percentile has decreased for age and weight (accounting for growth in height)

Approval duration

3 months initial, 1 year continuation